Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1995 Feb;69(2):840–848. doi: 10.1128/jvi.69.2.840-848.1995

Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain.

A Budkowska 1, P Bedossa 1, F Groh 1, A Louise 1, J Pillot 1
PMCID: PMC188650  PMID: 7815551

Abstract

Anti-idiotypic antibodies (anti-Ids) have been successfully used to characterize and isolate receptors of several cell ligands. To prepare an immunological probe for identification of cellular components interacting with the hepatitis B virus (HBV), polyclonal antisera against a panel of five HBV-specific monoclonal antibodies (MAbs) were produced in syngeneic BALB/c mice. MAbs to HBV used for immunization (Ab1) recognized biologically important and potentially neutralizing epitopes, located in the pre-S1, pre-S2, or S region-encoded domains of HBV proteins. All the anti-Ids (Ab2) were specific to idiotopes of the homologous Ab1 and inhibited their interaction with the corresponding viral epitopes, suggesting that they recognized unique determinants on the paratope of each immunizing Ab1. Therefore, all five generated polyclonal anti-Ids were of the Ab2 beta type and could represent internal images of viral epitopes. Ab2 raised against the pre-S2 region-specific MAb F124 bound to the extracellular matrix fibronectin of human liver sinusoids. Immunohistochemical studies demonstrated the attachment of viral and recombinant (S, M) hepatitis B surface antigen particles with the pre-S2 region-encoded epitopes to the fibronectin of human liver sinusoids. In contrast, recombinant (S, L*) hepatitis B surface antigen particles, in which the epitope recognized by F124 MAb was not expressed, did not show any binding capacity. These findings suggest that human liver fibronectin may bind HBV in vivo by the pre-S2 region-encoded epitopes in a species-restricted manner. Furthermore, binding of the circulating virus to liver sinusoids could facilitate its subsequent uptake by hepatocytes.

Full Text

The Full Text of this article is available as a PDF (803.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baxt B., Garmendia A. E., Morgan D. O. Characterization of anti-idiotypic antibodies generated against foot-and-mouth disease virus neutralizing monoclonal antibodies. Viral Immunol. 1989;2(2):103–113. doi: 10.1089/vim.1989.2.103. [DOI] [PubMed] [Google Scholar]
  2. Budkowska A., Quan C., Groh F., Bedossa P., Dubreuil P., Bouvet J. P., Pillot J. Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor. J Virol. 1993 Jul;67(7):4316–4322. doi: 10.1128/jvi.67.7.4316-4322.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Budkowska A., Riottot M. M., Dubreuil P., Lazizi Y., Brechot C., Sobczak E., Petit M. A., Pillot J. Monoclonal antibody recognizing pre-S(2) epitope of hepatitis B virus: characterization of pre-S(2) epitope and anti-pre-S(2) antibody. J Med Virol. 1986 Oct;20(2):111–125. doi: 10.1002/jmv.1890200204. [DOI] [PubMed] [Google Scholar]
  4. Colucci G., Beazer Y., Waksal S. D. Interactions between hepatitis B virus and polymeric human serum albumin. II. Development of syngeneic monoclonal anti-anti-idiotypes which mimic hepatitis B surface antigen in the induction of immune responsiveness. Eur J Immunol. 1987 Mar;17(3):371–374. doi: 10.1002/eji.1830170311. [DOI] [PubMed] [Google Scholar]
  5. Corre J. P., Février M., Chamaret S., Thèze J., Zouali M. Anti-idiotypic antibodies to human anti-gp120 antibodies bind recombinant and cellular human CD4. Eur J Immunol. 1991 Mar;21(3):743–751. doi: 10.1002/eji.1830210330. [DOI] [PubMed] [Google Scholar]
  6. Davis S. J., Schockmel G. A., Somoza C., Buck D. W., Healey D. G., Rieber E. P., Reiter C., Williams A. F. Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors. Nature. 1992 Jul 2;358(6381):76–79. doi: 10.1038/358076a0. [DOI] [PubMed] [Google Scholar]
  7. Ertl H. C., Bona C. A. Criteria to define anti-idiotypic antibodies carrying the internal image of an antigen. Vaccine. 1988 Apr;6(2):80–84. doi: 10.1016/s0264-410x(88)80003-3. [DOI] [PubMed] [Google Scholar]
  8. Ey P. L., Prowse S. J., Jenkin C. R. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 1978 Jul;15(7):429–436. doi: 10.1016/0161-5890(78)90070-6. [DOI] [PubMed] [Google Scholar]
  9. Flock J. I., Fröman G., Jönsson K., Guss B., Signäs C., Nilsson B., Raucci G., Hök M., Wadström T., Lindberg M. Cloning and expression of the gene for a fibronectin-binding protein from Staphylococcus aureus. EMBO J. 1987 Aug;6(8):2351–2357. doi: 10.1002/j.1460-2075.1987.tb02511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Foidart J. M., Berman J. J., Paglia L., Rennard S., Abe S., Perantoni A., Martin G. R. Synthesis of fibronectin, laminin, and several collagens by a liver-derived epithelial line. Lab Invest. 1980 May;42(5):525–532. [PubMed] [Google Scholar]
  11. Franco A., Paroli M., Testa U., Benvenuto R., Peschle C., Balsano F., Barnaba V. Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes. J Exp Med. 1992 May 1;175(5):1195–1205. doi: 10.1084/jem.175.5.1195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gaulton G. N., Greene M. I. Idiotypic mimicry of biological receptors. Annu Rev Immunol. 1986;4:253–280. doi: 10.1146/annurev.iy.04.040186.001345. [DOI] [PubMed] [Google Scholar]
  13. Gerlich W. H., Lu X., Heermann K. H. Studies on the attachment and penetration of hepatitis B virus. J Hepatol. 1993;17 (Suppl 3):S10–S14. doi: 10.1016/s0168-8278(05)80417-9. [DOI] [PubMed] [Google Scholar]
  14. Haywood A. M. Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol. 1994 Jan;68(1):1–5. doi: 10.1128/jvi.68.1.1-5.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hertogs K., Leenders W. P., Depla E., De Bruin W. C., Meheus L., Raymackers J., Moshage H., Yap S. H. Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope protein. Virology. 1993 Dec;197(2):549–557. doi: 10.1006/viro.1993.1628. [DOI] [PubMed] [Google Scholar]
  16. Itoh Y., Takai E., Ohnuma H., Kitajima K., Tsuda F., Machida A., Mishiro S., Nakamura T., Miyakawa Y., Mayumi M. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9174–9178. doi: 10.1073/pnas.83.23.9174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Julkunen I., Hautanen A., Keski-Oja J. Interaction of viral envelope glycoproteins with fibronectin. Infect Immun. 1983 Jun;40(3):876–881. doi: 10.1128/iai.40.3.876-881.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Julkunen I., Vartio T., Keski-Oja J. Localization of viral-envelope-glycoprotein-binding sites in fibronectin. Biochem J. 1984 Apr 15;219(2):425–428. doi: 10.1042/bj2190425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kauffman R. S., Noseworthy J. H., Nepom J. T., Finberg R., Fields B. N., Greene M. I. Cell receptors for the mammalian reovirus. II. Monoclonal anti-idiotypic antibody blocks viral binding to cells. J Immunol. 1983 Nov;131(5):2539–2541. [PubMed] [Google Scholar]
  20. Kennedy R. C., Adler-Storthz K., Henkel R. D., Sanchez Y., Melnick J. L., Dreesman G. R. Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype. Science. 1983 Aug 26;221(4613):853–855. doi: 10.1126/science.6603657. [DOI] [PubMed] [Google Scholar]
  21. Klotz S. A., Smith R. L. A fibronectin receptor on Candida albicans mediates adherence of the fungus to extracellular matrix. J Infect Dis. 1991 Mar;163(3):604–610. doi: 10.1093/infdis/163.3.604. [DOI] [PubMed] [Google Scholar]
  22. Linthicum D. S., Bolger M. B., Kussie P. H., Albright G. M., Linton T. A., Combs S., Marchetti D. Analysis of idiotypic and anti-idiotypic antibodies as models of receptor and ligand. Clin Chem. 1988 Sep;34(9):1676–1680. [PubMed] [Google Scholar]
  23. Marriott S. J., Roeder D. J., Consigli R. A. Anti-idiotypic antibodies to a polyomavirus monoclonal antibody recognize cell surface components of mouse kidney cells and prevent polyomavirus infection. J Virol. 1987 Sep;61(9):2747–2753. doi: 10.1128/jvi.61.9.2747-2753.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mason A., Wick M., White H., Perrillo R. Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology. 1993 Oct;18(4):781–789. doi: 10.1002/hep.1840180406. [DOI] [PubMed] [Google Scholar]
  25. Mehdi H., Kaplan M. J., Anlar F. Y., Yang X., Bayer R., Sutherland K., Peeples M. E. Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol. 1994 Apr;68(4):2415–2424. doi: 10.1128/jvi.68.4.2415-2424.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Michel M. L., Pontisso P., Sobczak E., Malpièce Y., Streeck R. E., Tiollais P. Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7708–7712. doi: 10.1073/pnas.81.24.7708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Neurath A. R., Adamowicz P., Kent S. B., Riottot M. M., Strick N., Parker K., Offensperger W., Petit M. A., Wahl S., Budkowska A. Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein. Mol Immunol. 1986 Sep;23(9):991–997. doi: 10.1016/0161-5890(86)90130-6. [DOI] [PubMed] [Google Scholar]
  28. Neurath A. R., Kent S. B., Strick N., Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell. 1986 Aug 1;46(3):429–436. doi: 10.1016/0092-8674(86)90663-x. [DOI] [PubMed] [Google Scholar]
  29. Neurath A. R., Seto B., Strick N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine. 1989 Jun;7(3):234–236. doi: 10.1016/0264-410x(89)90235-1. [DOI] [PubMed] [Google Scholar]
  30. Neurath A. R., Strick N., Li Y. Y. Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein. J Exp Med. 1992 Dec 1;176(6):1561–1569. doi: 10.1084/jem.176.6.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ouaissi M. A., Cornette J., Afchain D., Capron A., Gras-Masse H., Tartar A. Trypanosoma cruzi infection inhibited by peptides modeled from a fibronectin cell attachment domain. Science. 1986 Oct 31;234(4776):603–607. doi: 10.1126/science.3094145. [DOI] [PubMed] [Google Scholar]
  32. Petit M. A., Capel F., Dubanchet S., Mabit H. PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes. Virology. 1992 Mar;187(1):211–222. doi: 10.1016/0042-6822(92)90309-d. [DOI] [PubMed] [Google Scholar]
  33. Petre J., Rutgers T., Hauser P. Properties of a recombinant yeast-derived hepatitis B surface antigen containing S, preS2 and preS1 antigenic domains. Arch Virol Suppl. 1992;4:137–141. doi: 10.1007/978-3-7091-5633-9_30. [DOI] [PubMed] [Google Scholar]
  34. Pontisso P., Petit M. A., Bankowski M. J., Peeples M. E. Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region. J Virol. 1989 May;63(5):1981–1988. doi: 10.1128/jvi.63.5.1981-1988.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pontisso P., Ruvoletto M. G., Tiribelli C., Gerlich W. H., Ruol A., Alberti A. The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface. J Gen Virol. 1992 Aug;73(Pt 8):2041–2045. doi: 10.1099/0022-1317-73-8-2041. [DOI] [PubMed] [Google Scholar]
  36. Pottratz S. T., Paulsrud J. R., Smith J. S., Martin W. J., 2nd Evidence for Pneumocystis carinii binding to a cell-free substrate: role of the adhesive protein fibronectin. J Lab Clin Med. 1994 Feb;123(2):273–281. [PubMed] [Google Scholar]
  37. Seelig R., Pott G., Seelig H. P., Liehr H., Metzger P., Waldherr R. Virus-binding activity of fibronectin: masking of hepatitis A virus. J Virol Methods. 1984 Jul;8(4):335–347. doi: 10.1016/0166-0934(84)90071-5. [DOI] [PubMed] [Google Scholar]
  38. Sege K., Peterson P. A. Use of anti-idiotypic antibodies as cell-surface receptor probes. Proc Natl Acad Sci U S A. 1978 May;75(5):2443–2447. doi: 10.1073/pnas.75.5.2443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Stanislawski L. Attachment of rous sarcoma virus to the fibronectin matrix of infected chick embryo fibroblasts. J Ultrastruct Res. 1983 Feb;82(2):134–142. doi: 10.1016/s0022-5320(83)90048-5. [DOI] [PubMed] [Google Scholar]
  40. Strosberg A. D. Interaction of anti-idiotypic antibodies with membrane receptors: practical considerations. Methods Enzymol. 1989;178:179–191. doi: 10.1016/0076-6879(89)78015-0. [DOI] [PubMed] [Google Scholar]
  41. Torre D., Pugliese A., Ferrario G., Marietti G., Forno B., Zeroli C. Interaction of human plasma fibronectin with viral proteins of human immunodeficiency virus. FEMS Immunol Med Microbiol. 1994 Feb;8(2):127–131. doi: 10.1111/j.1574-695X.1994.tb00434.x. [DOI] [PubMed] [Google Scholar]
  42. Xue W., Minocha H. C. Identification of the cell surface receptor for bovine viral diarrhoea virus by using anti-idiotypic antibodies. J Gen Virol. 1993 Jan;74(Pt 1):73–79. doi: 10.1099/0022-1317-74-1-73. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES